6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
6m ago	ProWood TrueFrame Joist Now Available Across Northeast, South Atlantic
6m ago	Parker to Acquire CIRCOR’s Commercial and Defense Aerospace Business
6m ago	Toll Brothers Announces Cedar Terrace Community Now Open in Chantilly, Virginia
7m ago	When Blood Compatibility Becomes a Pregnancy Risk
7m ago	Tony and Grammy Award-Winning Leslie Odom, Jr. to Headline Blackbaud's bbcon 2026 Social Impact Tech Conference

About

293.01USD-5.47 -1.83%

Closed • Updated at 13:54 GMT+00:00

Market Cap$39.12B

P/E Ratio69.62

Volume13.4K

Beta0.26

RSI44.06

Gross Margin80.83%

Health TechnologyPharmaceuticals: Major

Alnylam Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Alnylam Issues 2025 Corporate Responsibility Report

ULTOMIRIS Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden

MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award

Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Community Chat

Ask AI